Stefan L Zimmerman
Overview
Explore the profile of Stefan L Zimmerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
2683
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asatryan B, Rieder M, Murray B, Muller S, Tichnell C, Gasperetti A, et al.
Circ Genom Precis Med
. 2025 Feb;
:e004878.
PMID: 39968648
Background: Pathogenic/likely pathogenic (LP) desmin () variants cause heterogeneous cardiomyopathy and skeletal myopathy phenotypes. Limited data suggest a high incidence of major adverse cardiac events (MACEs), including cardiac conduction disease,...
2.
Mohseni A, Zandieh G, Porter K, Pozzessere C, Wagle A, Borhani A, et al.
Acad Radiol
. 2025 Feb;
PMID: 39893144
Cardiac amyloidosis is an infiltrative cardiomyopathy caused by the deposition of insoluble amyloid fibrils in the myocardium, leading to abnormal cardiac function and heart failure. Diagnosis is often challenging due...
3.
Xu L, Khoshknab M, Moss J, Yang L, Berger R, Chrispin J, et al.
JACC Clin Electrophysiol
. 2024 Oct;
10(11):2325-2336.
PMID: 39387745
Background: Ventricular tachycardia (VT) substrate in patients with nonischemic cardiomyopathy (NICM) is complex in distribution and intramural location. Objectives: This study sought to test the hypothesis that myocardial lipomatous metaplasia...
4.
Asatryan B, Rieder M, Murray B, Muller S, Tichnell C, Gasperetti A, et al.
medRxiv
. 2024 Sep;
PMID: 39252922
Background: Pathogenic/likely pathogenic (P/LP) desmin () variants cause heterogeneous cardiomyopathy and/or skeletal myopathy phenotypes. Limited data suggest a high incidence of major adverse cardiac events (MACE), including cardiac conduction disease...
5.
Rekker L, Muller S, Gasperetti A, Bourfiss M, Oerlemans M, Cramer M, et al.
J Cardiovasc Magn Reson
. 2024 Jul;
26(2):101059.
PMID: 38986843
Background: While late gadolinium enhancement (LGE) is proposed as a diagnostic criterion for arrhythmogenic right ventricular cardiomyopathy (ARVC), the potential of LGE to distinguish ARVC from differentials remains unknown. We...
6.
Ambade A, Naranjo M, Tuhy T, Yu R, Marimoutou M, Everett A, et al.
Am J Respir Cell Mol Biol
. 2024 Jun;
71(3):343-355.
PMID: 38861354
Numerous studies have demonstrated that endostatin (ES), a potent angiostatic peptide derived from collagen type XVIII α 1 chain and encoded by , is elevated in pulmonary arterial hypertension (PAH)....
7.
Cubero Salazar I, Lancaster A, Jani V, Montovano M, Kauffman M, Weller A, et al.
Eur Respir J
. 2024 Jun;
64(1).
PMID: 38843915
Background: Pulmonary arterial hypertension (PAH) is characterised by poor exercise tolerance. The contribution of right ventricular (RV) diastolic function to the augmentation of cardiac output during exercise is not known....
8.
Umair M, Asatryan B, Ghasabeh M, Bosman L, Murray B, Tichnell C, et al.
JACC Cardiovasc Imaging
. 2024 May;
17(9):1113-1115.
PMID: 38727643
No abstract available.
9.
Xu L, Khoshknab M, Moss J, Berger R, Chrispin J, Callans D, et al.
JACC Clin Electrophysiol
. 2024 May;
10(6):1135-1146.
PMID: 38703163
Background: Ventricular tachycardia (VT) recurrence rates remain high following ablation among patients with nonischemic cardiomyopathy (NICM). Objectives: This study sought to define the prevalence of lipomatous metaplasia (LM) in patients...
10.
Lammi M, Mukherjee M, Saketkoo L, Carey K, Hummers L, Hsu S, et al.
BMC Pulm Med
. 2024 Apr;
24(1):211.
PMID: 38689245
Background: Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc). An important component of SSc patient management is early detection and treatment of PH....